IDEAYA Biosciences, Inc. (IDYA)
NASDAQ$18.58
Market Cap
$1.63B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
633 of 924
Rank in Industry
361 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
IDYA Insider Trading Activity
IDYA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $8,430,175 | 4 | 100 |
Related Transactions
| WHITE MICHAEL ANTHONY | Chief Scientific Officer | 0 | $0 | 1 | $1.03M | $-1.03M |
| Hata Yujiro S | President and CEO | 0 | $0 | 3 | $7.4M | $-7.4M |
About IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers …
Insider Activity of IDEAYA Biosciences, Inc.
Over the last 12 months, insiders at IDEAYA Biosciences, Inc. have bought $0 and sold $8.43M worth of IDEAYA Biosciences, Inc. stock.
On average, over the past 5 years, insiders at IDEAYA Biosciences, Inc. have bought $3.45M and sold $11.67M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,062 shares for transaction amount of $67,408 was made by BVF PARTNERS L P/IL (10 percent owner) on 2020‑06‑30.
List of Insider Buy and Sell Transactions, IDEAYA Biosciences, Inc.
| 2024-05-29 | Sale | WHITE MICHAEL ANTHONY | Chief Scientific Officer | 28,500 0.038% | $36.24 | $1.03M | -15.37% | |
| 2024-05-16 | Sale | Hata Yujiro S | President and CEO | 34,433 0.0453% | $41.81 | $1.44M | -26.51% | |
| 2024-05-15 | Sale | Hata Yujiro S | President and CEO | 83,856 0.112% | $42.90 | $3.6M | -28.04% | |
| 2024-05-14 | Sale | Hata Yujiro S | President and CEO | 56,711 0.0746% | $41.61 | $2.36M | -26.76% | |
| 2024-02-09 | Sale | Hata Yujiro S | President and CEO | 23,557 0.0351% | $45.54 | $1.07M | -18.78% | |
| 2024-02-09 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.003% | $46.02 | $92,045 | -18.78% | |
| 2024-02-08 | Sale | Hata Yujiro S | President and CEO | 75,815 0.1121% | $45.15 | $3.42M | -16.75% | |
| 2024-02-01 | Sale | Hata Yujiro S | President and CEO | 628 0.0009% | $45.00 | $28,260 | -15.63% | |
| 2024-01-22 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0028% | $42.03 | $84,050 | -10.78% | |
| 2024-01-16 | Sale | Hata Yujiro S | President and CEO | 62,739 0.0965% | $40.17 | $2.52M | -5.95% | |
| 2024-01-12 | Sale | Hata Yujiro S | President and CEO | 12,261 0.0191% | $40.04 | $490,913 | -3.55% | |
| 2024-01-12 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.003% | $38.01 | $76,026 | -3.55% | |
| 2023-12-15 | Sale | Hata Yujiro S | President and CEO | 75,000 0.1165% | $35.03 | $2.63M | +9.30% | |
| 2023-12-15 | Sale | Throne Jason | Chief Legal Officer | 10,000 0.0155% | $35.04 | $350,371 | +9.30% | |
| 2023-12-14 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0031% | $34.00 | $68,002 | +12.01% | |
| 2023-11-03 | Sale | Throne Jason | Chief Legal Officer | 5,163 0.0085% | $30.09 | $155,360 | +32.35% | |
| 2023-09-12 | Sale | Throne Jason | Chief Legal Officer | 1,000 0.0018% | $30.00 | $30,005 | +30.25% | |
| 2023-09-05 | Sale | Throne Jason | Chief Legal Officer | 1,737 0.0031% | $30.03 | $52,160 | +32.78% | |
| 2023-09-01 | Sale | Ruiz Briseno Andres | See Remarks | 2,000 0.0035% | $30.01 | $60,016 | +28.50% | |
| 2023-09-01 | Sale | Throne Jason | Chief Legal Officer | 2,100 0.0037% | $30.03 | $63,063 | +28.50% |
Total: 66
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| DIEKMAN JOHN D | director | 2844545 3.2495% | $52.85M | 1 | 0 | <0.0001% |
| SHANNON TIMOTHY M | director | 2660713 3.0395% | $49.44M | 1 | 0 | <0.0001% |
| CANAAN X L.P. | 10 percent owner | 2660713 3.0395% | $49.44M | 1 | 0 | <0.0001% |
| Alexandria Venture Investments, LLC | 10 percent owner | 432384 0.4939% | $8.03M | 1 | 0 | <0.0001% |
| BVF PARTNERS L P/IL | 233150 0.2663% | $4.33M | 3 | 1 | <0.0001% |
Historical Insider Profitability vs. Competitors
$8,217,280 | 112 | 46.33% | $1.29B | |
$831,902,292 | 108 | 9.34% | $1.58B | |
$20,297,544 | 73 | 103.06% | $1.61B | |
$1,101,324,300 | 58 | 37.37% | $1.3B | |
$11,583,737 | 45 | 49.75% | $1.75B |
IDYA Institutional Investors: Active Positions
| Increased Positions | 129 | +64.5% | 11M | +11.46% |
| Decreased Positions | 88 | -44% | 8M | -9.08% |
| New Positions | 32 | New | 1M | New |
| Sold Out Positions | 34 | Sold Out | 4M | Sold Out |
| Total Postitions | 241 | +20.5% | 94M | +2.38% |
IDYA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Fmr Llc | $266,652.00 | 14.73% | 12.96M | +327,498 | +2.59% | 2024-12-31 |
| Blackrock, Inc. | $172,316.00 | 9.52% | 8.38M | +696,115 | +9.06% | 2024-12-31 |
| Janus Henderson Group Plc | $120,492.00 | 6.66% | 5.86M | +695,263 | +13.47% | 2024-12-31 |
| Vanguard Group Inc | $104,456.00 | 5.77% | 5.08M | +282,936 | +5.9% | 2024-12-31 |
| Federated Hermes, Inc. | $104,157.00 | 5.75% | 5.06M | -144,774 | -2.78% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $79,542.00 | 4.39% | 3.87M | -148,390 | -3.7% | 2024-12-31 |
| State Street Corp | $68,311.00 | 3.77% | 3.32M | +2,962 | +0.09% | 2024-12-31 |
| Logos Global Management Lp | $61,710.00 | 3.41% | 3M | +900,000 | +42.86% | 2024-12-31 |
| Deerfield Management Company, L.P. (Series C) | $56,280.00 | 3.11% | 2.74M | +142,000 | +5.47% | 2024-12-31 |
| Capital Research Global Investors | $52,781.00 | 2.92% | 2.57M | -459 | -0.02% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.